The efficacy of immunotherapy agents may depend on diverse molecular and cellular factors including immune infiltration and cell types within the tumor niche, mutational load and tumor foreignness, tumor differentiation states (e.g., epithelial vs. mesenchymal), presence of immune checkpoints, and sensitivity to immune effectors (e.g., IFNγ)7. This evidence concerns the gene IFNG and neoplasm.